| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Antoine Guéguen, Benoit Hijazi, Kevin Zuber, Romain Deschamps, Cedric Lamirel, Catherine Vignal-Clermont, Olivier Gou. Generalization of ocular myasthenia gravis 10 years after onset. Journal of neurology. 2022-08-24. PMID:36001142. |
generalization of ocular myasthenia gravis (omg) represents a pejorative evolution, and no validated generalization-prevention strategy exists. |
2022-08-24 |
2023-08-14 |
Not clear |
| Jinwei Zhang, Zeyang Zhang, Hui Zhang, Yuantao Cui, Yuan Chen, Peng Lv, Peng Zhan. Thymectomy in ocular myasthenia gravis-prognosis and risk factors analysis. Orphanet journal of rare diseases. vol 17. issue 1. 2022-08-09. PMID:35945595. |
several retrospective studies have identified risk factors associated with ocular myasthenia gravis (omg) generalization in non-surgical patients. |
2022-08-09 |
2023-08-14 |
Not clear |
| Zhe Ruan, Chao Sun, Yanlin Lang, Feng Gao, Rongjing Guo, Quan Xu, Liping Yu, Songdi Wu, Tao Lei, Yu Liu, Min Zhang, Huanhuan Li, Yonglan Tang, Ting Gao, Yanwu Gao, Xiaodan Lu, Zhuyi Li, Ting Chan. Development and Validation of a Nomogram for Predicting Generalization in Patients With Ocular Myasthenia Gravis. Frontiers in immunology. vol 13. 2022-07-25. PMID:35874731. |
this study aims to develop and validate a nomogram for predicting 1- and 2-year generalization probabilities in patients with ocular myasthenia gravis (omg). |
2022-07-25 |
2023-08-14 |
Not clear |
| Xian-Peng Xu, Yan-Bing Jiang, Li-Hua Guan, Qing-Jie Ji, Ying Ji. [Acupuncture combined with western medication for ocular myasthenia gravis: a randomized controlled trial]. Zhongguo zhen jiu = Chinese acupuncture & moxibustion. vol 42. issue 7. 2022-07-06. PMID:35793884. |
to compare the clinical efficacy between acupuncture combined with western medication and simple western medication for ocular myasthenia gravis (omg), and to explore its possible mechanism. |
2022-07-06 |
2023-08-14 |
Not clear |
| Jie Rao, Siyu Li, Qiyu Wang, Qi Cheng, Yu Ji, Wenwen Fu, Hui Huang, Ling Shi, Xiaorong W. Comparison of Peripheral Blood Regulatory T Cells and Functional Subsets Between Ocular and Generalized Myasthenia Gravis. Frontiers in medicine. vol 9. 2022-06-27. PMID:35755064. |
this study aims to discuss the function mechanism of regulatory t cells and its subsets in the pathogenic process of myasthenia gravis by contracting the activation levels of those cells in peripheral blood among healthy people, patients with ocular myasthenia gravis (omg) and patients with generalized myasthenia gravis (gmg). |
2022-06-27 |
2023-08-14 |
Not clear |
| Zhe Ruan, Rongjing Guo, Hongyu Zhou, Feng Gao, Ye Lin, Quan Xu, Liping Yu, Songdi Wu, Tao Lei, Min Zhang, Yanwu Gao, Xiaodan Lu, Huanhuan Li, Chao Sun, Baoli Tang, Zhuyi Li, Ting Chan. Association of immunosuppression treatment with generalization among patients with ocular myasthenia gravis: a propensity score analysis. European journal of neurology. 2022-02-21. PMID:35188698. |
to analyze disease generalization in patients with ocular myasthenia gravis (omg) treated with immunosuppression compared with patients without immunosuppression treatment. |
2022-02-21 |
2023-08-13 |
Not clear |
| Mingxia Li, Fangfang Ge, Rongjing Guo, Zhe Ruan, Yanwu Gao, Chunxiao Niu, Hong Lin, Zhengwei Zhao, Yongan Zhou, Zhuyi Li, Ting Chan. Do early prednisolone and other immunosuppressant therapies prevent generalization in ocular myasthenia gravis in Western populations: a systematic review and meta-analysis. Therapeutic advances in neurological disorders. vol 12. 2022-02-17. PMID:35173803. |
the majority of ocular myasthenia gravis (omg) patients will progress to generalized myasthenia gravis (gmg), usually within 2 years of disease onset. |
2022-02-17 |
2023-08-13 |
Not clear |
| Thanchat Jienmaneechotchai, Supanut Apinyawasisuk, Supharat Jariyakosol, Parima Hirunwiwatku. Interobserver and Intra-Observer Reliability of Eyelid Tests for Ocular Myasthenia Gravis. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. 2021-12-07. PMID:34860746. |
lid fatigability test (lft), cogan lid twitch (clt), and forced eyelids closure test (fect) are simple clinical screening tests for ocular myasthenia gravis (omg). |
2021-12-07 |
2023-08-13 |
Not clear |
| In Young Chung, Shivanand J Sheth, Kristen K Wells, Thomas G Campbel. The Usefulness of Anti-acetylcholine Receptor Binding Antibody Testing in Diagnosing Ocular Myasthenia Gravis. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. vol 41. issue 4. 2021-11-18. PMID:32868574. |
despite the test's high sensitivity (85%-90%) for generalized myasthenia gravis, achr-abs testing has been reported to have a low sensitivity 44%-66% for ocular myasthenia gravis (omg). |
2021-11-18 |
2023-08-13 |
Not clear |
| Rong-Jing Guo, Ting Gao, Zhe Ruan, Hong-Yu Zhou, Feng Gao, Quan Xu, Li-Ping Yu, Song-Di Wu, Tao Lei, Huan-Huan Li, Chao Sun, Min Zhang, Yan-Wu Gao, Xiao-Dan Lu, Yong-Lan Tang, Bao-Li Tang, Fei-Yan Huo, Ying Zhu, Zhu-Yi Li, Ting Chan. Risk Factors for Generalization in Patients with Ocular Myasthenia Gravis: A Multicenter Retrospective Cohort Study. Neurology and therapy. 2021-11-03. PMID:34729706. |
many patients with ocular myasthenia gravis (omg) progress to generalized disease within the first 2 years of the onset of ocular symptoms. |
2021-11-03 |
2023-08-13 |
Not clear |
| Parinee Kemchoknatee, Apisama Arepagorn, Thansit Srisombu. Ocular manifestation and generalization after ocular onset in ocular myasthenia gravis: A 5-year analysis. Asian Pacific journal of allergy and immunology. 2021-10-31. PMID:34717528. |
ocular myasthenia gravis (omg) is an autoimmune disease which causes ptosis, diplopia, or both. |
2021-10-31 |
2023-08-13 |
Not clear |
| Gary R Cutter, Donald B Sander. If Thymectomy Reduces the Risk of Progression of Ocular to Generalized Myasthenia Gravis, Who Should Receive it? Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 2021-10-15. PMID:34651292. |
report a large retrospective study of the beneficial effects of thymectomy on the progression of ocular myasthenia gravis (omg) to generalized mg (gmg) (huanhuan et al. |
2021-10-15 |
2023-08-13 |
Not clear |
| Georgios Velonakis, Vassilis E Papadopoulos, Efstratios Karavasilis, Dimitrios K Filippiadis, Vasiliki Zouvelo. MRI evidence of extraocular muscle atrophy and fatty replacement in myasthenia gravis. Neuroradiology. vol 63. issue 9. 2021-09-29. PMID:34232334. |
the aim of the study was to evaluate extraocular muscle (eom) atrophy and fatty replacement in ocular myasthenia gravis (omg) and generalized myasthenia gravis (gmg) patients with chronic and untreated ocular symptoms or with inadequate response to immunotherapy and unprovoked ocular exacerbations despite chronic immunotherapy. |
2021-09-29 |
2023-08-13 |
Not clear |
| Kristen S Fisher, Jason Gill, Hannah F Todd, Michael B Yang, Michael A Lopez, Farida Abid, Timothy Lotze, Veeral S Sha. Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort. Pediatric neurology. vol 118. 2021-09-20. PMID:33684630. |
ocular myasthenia gravis (omg) is localized, affecting only extraocular and/or levator palpebrae muscles. |
2021-09-20 |
2023-08-13 |
Not clear |
| Yoshihiko Isshiki, Osamu Mimura, Fumi Gom. Clinical features and treatment status of antiacetylcholine receptor antibody-positive ocular myasthenia gravis. Japanese journal of ophthalmology. vol 64. issue 6. 2021-08-18. PMID:32936398. |
to clarify the factors predictive of progression from ocular myasthenia gravis (omg) to generalized mg (gmg) among patients with positive antiacetylcholine receptor antibodies (achrab) and to evaluate the efficacy of our omg treatment protocol including tacrolimus (tac). |
2021-08-18 |
2023-08-13 |
Not clear |
| Hyuna Kim, Shin Yeop O. Diagnostic yields and clinical features of ocular myasthenia gravis. Medicine. vol 100. issue 25. 2021-06-29. PMID:34160444. |
to investigate clinical features and diagnosis process of ocular myasthenia gravis (omg) in ophthalmology department.a total of 36 patients with ptosis or diplopia who had follow-up for at least 3 months between march 2016 and december 2019 were included in this study. |
2021-06-29 |
2023-08-13 |
Not clear |
| Juthamat Witthayaweerasak, Narisa Rattanalert, Nipat Aui-Are. Prognostic factors for conversion to generalization in ocular myasthenia gravis. Medicine. vol 100. issue 19. 2021-06-22. PMID:34106649. |
patients with ocular myasthenia gravis (omg) are frequently treated to prevent the development of generalized myasthenia gravis (gmg). |
2021-06-22 |
2023-08-13 |
Not clear |
| Feng Li, Zhongmin Li, Yanli Chen, Gero Bauer, Deniz Uluk, Aron Elsner, Marc Swierzy, Mahmoud Ismail, Andreas Meisel, Jens-C Rücker. Thymectomy in ocular myasthenia gravis before generalization results in a higher remission rate. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. vol 57. issue 3. 2021-06-21. PMID:31628812. |
this study aimed to compare the outcomes of patients with ocular myasthenia gravis (omg) who underwent thymectomy before generalization with the outcomes of those who underwent thymectomy after generalization. |
2021-06-21 |
2023-08-13 |
Not clear |
| Benjamin Claytor, Yuebing L. Challenges in diagnosing coexisting ocular myasthenia gravis and thyroid eye disease. Muscle & nerve. vol 63. issue 5. 2021-06-10. PMID:33247453. |
ocular myasthenia gravis (omg) and thyroid eye disease are two autoimmune conditions that have several overlapping clinical features, and these coexist with a small but not insignificant frequency. |
2021-06-10 |
2023-08-13 |
Not clear |
| Ali G Hamedani, Maxwell Pistilli, Sunil Singhal, Kenneth S Shindler, Robert A Avery, Madhura A Tamhankar, Grant T Li. Outcomes After Transcervical Thymectomy for Ocular Myasthenia Gravis: A Retrospective Cohort Study With Inverse Probability Weighting. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society. vol 40. issue 1. 2021-05-28. PMID:31453917. |
it is unclear whether this benefit applies to patients with myasthenia and purely ocular manifestations (ocular myasthenia gravis [omg]). |
2021-05-28 |
2023-08-13 |
Not clear |